FCGR2A
Basic information
Region (hg38): 1:161505430-161524013
Previous symbols: [ "FCG2", "FCGR2A1", "FCGR2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FCGR2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 17 | 25 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 18 | 8 | 7 |
Variants in FCGR2A
This is a list of pathogenic ClinVar variants found in the FCGR2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-161505489-T-C | not specified | Uncertain significance (May 14, 2024) | ||
1-161506371-G-A | FCGR2A-related disorder | Likely benign (May 28, 2019) | ||
1-161506380-C-T | FCGR2A-related disorder | Likely benign (Apr 12, 2019) | ||
1-161506414-C-T | not specified • FCGR2A-related disorder | Benign (Mar 28, 2016) | ||
1-161506415-A-G | not specified • FCGR2A-related disorder | Benign (Mar 28, 2016) | ||
1-161506437-C-T | Benign/Likely benign (Apr 01, 2024) | |||
1-161506448-A-C | not specified | Uncertain significance (May 18, 2022) | ||
1-161506484-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
1-161506508-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
1-161506532-A-G | not specified | Uncertain significance (Oct 25, 2024) | ||
1-161506535-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-161506568-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
1-161506590-C-T | Likely benign (-) | |||
1-161509809-G-A | not specified | Benign (Mar 28, 2016) | ||
1-161509873-A-G | Likely benign (Jul 01, 2024) | |||
1-161509904-C-G | not specified | Uncertain significance (Feb 06, 2023) | ||
1-161509952-C-T | Malaria, susceptibility to;Systemic lupus erythematosus;Cystic fibrosis | Uncertain significance (Jul 14, 2021) | ||
1-161509955-A-G | Lupus nephritis, susceptibility to • Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis • Malaria, severe, susceptibility to • not specified | Benign (Mar 28, 2016) | ||
1-161509964-C-T | not specified | Uncertain significance (Nov 08, 2024) | ||
1-161509967-C-A | not specified | Likely benign (Nov 11, 2024) | ||
1-161509969-T-C | not specified | Uncertain significance (Nov 07, 2022) | ||
1-161510069-T-C | not specified | Uncertain significance (Nov 09, 2021) | ||
1-161510840-G-C | not specified | Uncertain significance (May 30, 2023) | ||
1-161510849-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
1-161510859-A-G | not specified | Benign (Mar 28, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FCGR2A | protein_coding | protein_coding | ENST00000271450 | 7 | 18584 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000201 | 0.470 | 101421 | 1800 | 22527 | 125748 | 0.102 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.352 | 161 | 174 | 0.925 | 0.00000914 | 2085 |
Missense in Polyphen | 46 | 66.333 | 0.69347 | 843 | ||
Synonymous | -1.16 | 81 | 68.8 | 1.18 | 0.00000402 | 610 |
Loss of Function | 0.675 | 10 | 12.6 | 0.795 | 5.44e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0891 | 0.0892 |
Ashkenazi Jewish | 0.256 | 0.255 |
East Asian | 0.000599 | 0.000598 |
Finnish | 0.120 | 0.120 |
European (Non-Finnish) | 0.130 | 0.130 |
Middle Eastern | 0.000599 | 0.000598 |
South Asian | 0.0890 | 0.0875 |
Other | 0.132 | 0.131 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens. {ECO:0000269|PubMed:19011614}.;
- Pathway
- Platelet activation - Homo sapiens (human);Fc gamma R-mediated phagocytosis - Homo sapiens (human);Systemic lupus erythematosus - Homo sapiens (human);Phagosome - Homo sapiens (human);Staphylococcus aureus infection - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Leishmaniasis - Homo sapiens (human);Osteoclast differentiation - Homo sapiens (human);Spinal Cord Injury;Neutrophil degranulation;FCGR activation;Role of phospholipids in phagocytosis;Fcgamma receptor (FCGR) dependent phagocytosis;Innate Immune System;Immune System;Regulation of actin dynamics for phagocytic cup formation;Signaling events mediated by PTP1B;Beta2 integrin cell surface interactions
(Consensus)
Intolerance Scores
- loftool
- 0.871
- rvis_EVS
- 0.84
- rvis_percentile_EVS
- 88.36
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- N
- hipred_score
- 0.304
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00251
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fcgr3
- Phenotype
- immune system phenotype; skeleton phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- Fc-gamma receptor signaling pathway involved in phagocytosis;neutrophil degranulation
- Cellular component
- plasma membrane;integral component of membrane;secretory granule membrane
- Molecular function
- protein binding;IgG binding